ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Nov. 5, 2007
Medical plastics industry on the rebound
Chemical & Engineering News
In the wake of Dow Cornings bankrupting experience with silicone gel breast implants, the medical plastics industry is now undergoing a renaissance. Medical plastics are a $1 billion a year market and demand is growing at 10 to 20 percent a year. Driving this growth are the demands of an aging population for implantable medical devices, such as artificial hips and knees, according to an article scheduled for the November 5 issue of Chemical & Engineering News, ACS weekly newsmagazine.
The demand continues to rise for devices incorporating plastics such as artery-opening stents, heart pacemakers, and other products that improve quality of life for an aging population. To meet this growing need, medical device makers are creating new types of implants with novel properties, writes C&EN senior correspondent Marc S. Reisch. New legal protections for plastic material makers that werent available a decade ago also fuel the industrys growth, he notes.
In the article, Reisch interviews both new and established companies about the current state of the medical plastics industry. He finds that some larger companies are still reluctant to enter the medical device market because of its potential legal risks, while some smaller companies are aggressively forging ahead to tap into its promises. Others see great opportunities in providing the raw materials for making the devices without becoming directly involved in their manufacture. Nevertheless, the medical plastics industry appears to be on a big rebound.
ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Nov. 5, 2007
Medical polymers renaissance
This story will be available on Nov. 5 at http://pubs.acs.org/cen/business
'/>"/>
| Contact: Michael Bernstein m_bernstein@acs.org 202-872-4400 American Chemical Society Source:Eurekalert |